• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 14681

10-year publication summary

570
997
1224
1208
1433
1492
1578
1715
1871
1493
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Regeneron Pharmaceuticals, Inc.
4800
252
SeaGen Inc
532
243
Daiichi Sankyo Company, Limited
1889
237
Genentech, Inc.
4123
205
Hanmi Pharm. Co., Ltd.
602
159
Dyne Therapeutics, Inc.
262
151
MedImmune Limited
612
145
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
399
139
ImmunoGen, Inc.
375
126
The Regents of the University of California
20868
124
Bristol-myers Squibb Company
4757
108
Novartis AG
10174
90
Bolt Biotherapeutics, Inc.
109
83
Shanghai Hengrui Pharmaceutical Co., Ltd.
720
79
Sanofi
4323
74
Zymeworks Inc.
258
71
Genmab A/S
477
71
Hoffmann-La Roche Inc.
3832
70
Pfizer Inc.
3414
70
Yale University
2565
70
Other owners 12114